172 related articles for article (PubMed ID: 27754875)
1. Global analysis of pre-mRNA subcellular localization following splicing inhibition by spliceostatin A.
Yoshimoto R; Kaida D; Furuno M; Burroughs AM; Noma S; Suzuki H; Kawamura Y; Hayashizaki Y; Mayeda A; Yoshida M
RNA; 2017 Jan; 23(1):47-57. PubMed ID: 27754875
[TBL] [Abstract][Full Text] [Related]
2. Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA.
Kaida D; Motoyoshi H; Tashiro E; Nojima T; Hagiwara M; Ishigami K; Watanabe H; Kitahara T; Yoshida T; Nakajima H; Tani T; Horinouchi S; Yoshida M
Nat Chem Biol; 2007 Sep; 3(9):576-83. PubMed ID: 17643111
[TBL] [Abstract][Full Text] [Related]
3. Spliceostatin A inhibits spliceosome assembly subsequent to prespliceosome formation.
Roybal GA; Jurica MS
Nucleic Acids Res; 2010 Oct; 38(19):6664-72. PubMed ID: 20529876
[TBL] [Abstract][Full Text] [Related]
4. Spliceostatin A stabilizes CDKN1B mRNA through the 3' UTR.
Kaida D; Shida K
Biochem Biophys Res Commun; 2022 Jun; 608():39-44. PubMed ID: 35381427
[TBL] [Abstract][Full Text] [Related]
5. Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A.
Corrionero A; Miñana B; Valcárcel J
Genes Dev; 2011 Mar; 25(5):445-59. PubMed ID: 21363963
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of p27 cyclin-dependent kinase inhibitor and a C-terminus truncated form of p27 contributes to G1 phase arrest.
Satoh T; Kaida D
Sci Rep; 2016 Jun; 6():27829. PubMed ID: 27282251
[TBL] [Abstract][Full Text] [Related]
7. Spliceostatin A interaction with SF3B limits U1 snRNP availability and causes premature cleavage and polyadenylation.
Yoshimoto R; Chhipi-Shrestha JK; Schneider-Poetsch T; Furuno M; Burroughs AM; Noma S; Suzuki H; Hayashizaki Y; Mayeda A; Nakagawa S; Kaida D; Iwasaki S; Yoshida M
Cell Chem Biol; 2021 Sep; 28(9):1356-1365.e4. PubMed ID: 33784500
[TBL] [Abstract][Full Text] [Related]
8.
Kikuchi K; Kaida D
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769053
[TBL] [Abstract][Full Text] [Related]
9. Spliceostatin A blocks angiogenesis by inhibiting global gene expression including VEGF.
Furumai R; Uchida K; Komi Y; Yoneyama M; Ishigami K; Watanabe H; Kojima S; Yoshida M
Cancer Sci; 2010 Nov; 101(11):2483-9. PubMed ID: 20726856
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of splicing and nuclear retention of pre-mRNA by spliceostatin A in fission yeast.
Lo CW; Kaida D; Nishimura S; Matsuyama A; Yashiroda Y; Taoka H; Ishigami K; Watanabe H; Nakajima H; Tani T; Horinouchi S; Yoshida M
Biochem Biophys Res Commun; 2007 Dec; 364(3):573-7. PubMed ID: 17961508
[TBL] [Abstract][Full Text] [Related]
11. Interactions between SAP155 and FUSE-binding protein-interacting repressor bridges c-Myc and P27Kip1 expression.
Matsushita K; Tamura M; Tanaka N; Tomonaga T; Matsubara H; Shimada H; Levens D; He L; Liu J; Yoshida M; Nomura F
Mol Cancer Res; 2013 Jul; 11(7):689-98. PubMed ID: 23594796
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a monitoring system to detect inhibition of mRNA processing.
Fujita K; Okamura M; Nishimoto S; Kurihara T; Momma K; Miyamae Y; Kambe T; Nagao M; Narita H; Masuda S
Biosci Biotechnol Biochem; 2012; 76(6):1248-51. PubMed ID: 22790958
[TBL] [Abstract][Full Text] [Related]
13. U2 snRNP is required for expression of the 3' end of genes.
Koga M; Satoh T; Takasaki I; Kawamura Y; Yoshida M; Kaida D
PLoS One; 2014; 9(5):e98015. PubMed ID: 24845214
[TBL] [Abstract][Full Text] [Related]
14. Identification of SAP155 as the target of GEX1A (Herboxidiene), an antitumor natural product.
Hasegawa M; Miura T; Kuzuya K; Inoue A; Won Ki S; Horinouchi S; Yoshida T; Kunoh T; Koseki K; Mino K; Sasaki R; Yoshida M; Mizukami T
ACS Chem Biol; 2011 Mar; 6(3):229-33. PubMed ID: 21138297
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis of differential 3' splice site sensitivity to anti-tumor drugs targeting U2 snRNP.
Vigevani L; Gohr A; Webb T; Irimia M; Valcárcel J
Nat Commun; 2017 Dec; 8(1):2100. PubMed ID: 29235465
[TBL] [Abstract][Full Text] [Related]
16. Splicing inhibition induces gene expression through canonical NF-κB pathway and extracellular signal-related kinase activation.
Khan K; Schneider-Poetsch T; Ishfaq M; Ito A; Yoshimoto R; Mukaida N; Yoshida M
FEBS Lett; 2014 Mar; 588(6):1053-7. PubMed ID: 24561197
[TBL] [Abstract][Full Text] [Related]
17. Interplay between pre-mRNA splicing and microRNA biogenesis within the supraspliceosome.
Agranat-Tamir L; Shomron N; Sperling J; Sperling R
Nucleic Acids Res; 2014 Apr; 42(7):4640-51. PubMed ID: 24464992
[TBL] [Abstract][Full Text] [Related]
18. Multiple factors in the early splicing complex are involved in the nuclear retention of pre-mRNAs in mammalian cells.
Takemura R; Takeiwa T; Taniguchi I; McCloskey A; Ohno M
Genes Cells; 2011 Oct; 16(10):1035-49. PubMed ID: 21929696
[TBL] [Abstract][Full Text] [Related]
19. Spliceostatin A treatment inhibits mitotic clonal expansion and adipogenesis.
Kaida D
Biochem Biophys Res Commun; 2019 Jun; 514(3):848-852. PubMed ID: 31079922
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic insights into human pre-mRNA splicing of human ultra-short introns: potential unusual mechanism identifies G-rich introns.
Sasaki-Haraguchi N; Shimada MK; Taniguchi I; Ohno M; Mayeda A
Biochem Biophys Res Commun; 2012 Jun; 423(2):289-94. PubMed ID: 22640740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
